ITGB3 and cardiovascular disorder: From this result, two lncRNAs AP001033.3–201 and AC068234.2–202, and two potential target genes, integrin beta-3 (ITGB3) and thromboxane A2 receptor (TBXA2R), were identified to be associated with cardiovascular disease and involved in the platelet activation pathway [62].